Key Points
-
Members of the β-lactam family of antibiotics (penicillins, cephalosporins/cephamycins, monobactams, clavams and carbapenems) function by interfering with bacterial cell wall biosynthesis and are in widespread clinical use for the treatment of bacterial infections.
-
Carbapenems are of particular interest because they are often resistant to the many β-lactamase enzymes that are produced by clinically important bacterial pathogens. β-lactamases commonly confer resistance to penicillin and cephalosporin-related antibiotics.
-
Carbapenem-producing organisms include Streptomyces cattleya, which produces thienamycin, and a few Gram-negative bacterial species, including Erwinia carotovora subsp. carotovora, Serratia sp. strain ATCC39006 and Photorhabdus luminescens, which all produce Car (1-carbapen-2-em-3-carboxylic acid).
-
The E. c. carotovora and Serratia ATCC39006 carA–H biosynthetic operons encode genes that are involved in Car biosynthesis (carA–E) and genes that are required for the Car resistance mechanism (carF and carG). Expression of the carA–H operon in E. c. carotovora and Serratia ATCC39006 is regulated by the Hor/Rap transcriptional regulators, respectively. Expression is also regulated by quorum sensing (cell density-dependent) control in both bacteria — although the underlying mechanisms are different. Physiological cues that affect Car production in Erwinia spp. include temperature, oxygen availability and carbon source.
-
The core biosynthetic enzymes are CarA (carbapenam synthetase), CarB (carboxymethylproline synthase) and CarC (carbapenem synthase). CarB (similar to enoyl coenzyme A (CoA) hydratase enzymes) condenses malonyl-CoA and glutamate semialdehyde to form (2S,5S)-carboxymethyl proline (CMP), which is the substrate for the CarA enzyme. CarA catalyses the ATP-dependent formation of (3S,5S)-carbapenam from CMP, resulting in the closure of the β-lactam ring. Finally, CarC acts on the carbapenam product of CarA to introduce a double bond and to produce a stereoinversion, thereby forming the active molecule, carbapenem.
-
Homologues of CarA and CarC (β-lactam synthetase and clavaminate synthase, respectively) function in clavulanic acid biosynthesis in Streptomyces clavuligerus, and the Car and clavulanate biosynthesis pathways have some similarities. Putative homologues of carA (thnM) and carB (thnE) have been found in the thnA–V operon required for thienamycin biosynthesis in S. cattleya, and a biosynthetic pathway for thienamycin has been proposed.
-
An improved understanding of carbapenem biosynthesis might pave the way towards the development of novel carbapenems that have useful chemotherapeutic activities.
Abstract
Carbapenem antibiotics are members of the β-lactam family of antibiotics, the most important class of antibiotics currently in clinical use. They are active against many important Gram-positive and Gram-negative pathogens. One important feature of carbapenem antibiotics is their resistance to several β-lactamases. Thienamycin, isolated from Streptomyces cattleya, was the first carbapenem described. Other well-studied carbapenems were isolated from the Gram-negative bacteria Erwinia carotovora subsp. carotovora, Serratia sp. strain ATCC39006 and Photorhabdus luminescens strain TT01. Here, we review the genetics and biochemistry of carbapenem production in these bacteria. Research into carbapenems could uncover a new repertoire of bioactive molecules and biosynthetic enzymes, and exploiting these novel enzymes could lead to development of new classes of antibiotics with useful chemotherapeutic activities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Elander, R. P. Industrial production of β-lactam antibiotics. Appl. Microbiol. Biotechnol. 61, 385–392 (2003).
Fleming, A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 10, 226–236 (1929).
Tipper, D. J. & Strominger, J. L. Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc. Natl Acad. Sci. USA 54, 1133–1141 (1965).
Bradley, J. S. et al. Carbapenems in clinical practice: a guide to their use in serious infection. Int. J. Antimicrob. Agents 11, 93–100 (1999).
Kahan, J. S. et al. Thienamycin, a new β-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J. Antibiot. (Tokyo) 32, 1–12 (1979).
Nunez, L. E., Mendez, C., Brana, A. F., Blanco, G. & Salas, J. A. The biosynthetic gene cluster for the β-lactam carbapenem thienamycin in Streptomyces cattleya. Chem. Biol. 10, 301–311 (2003). This long-awaited paper describes the cloning and sequencing of the thienamycin biosynthetic gene cluster from S. cattleya . This discovery paves the way for a comprehensive analysis of thienamycin biosynthesis and regulation.
Parker, W. L. et al. SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia. J. Antibiot. (Tokyo) 35, 653–660 (1982).
Derzelle, S., Duchaud, E., Kunst, F., Danchin, A. & Bertin, P. Identification, characterization, and regulation of a cluster of genes involved in carbapenem biosynthesis in Photorhabdus luminescens. Appl. Environ. Microbiol. 68, 3780–3789 (2002).
Livermore, D. M. β-Lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41 (Suppl. D), 25–41 (1998).
Hawkey, P. M. The origins and molecular basis of antibiotic resistance. BMJ 317, 657–660 (1998).
Livermore, D. M. Acquired carbapenemases. J. Antimicrob. Chemother. 39, 673–676 (1997).
Nordmann, P. & Poirel, L. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8, 321–331 (2002).
Rasmussen, B. A. & Bush, K. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41, 223–232 (1997).
Edwards, J. R. & Betts, M. J. Carbapenems: the pinnacle of the β-lactam antibiotics or room for improvement? J. Antimicrob. Chemother. 45, 1–4 (2000).
Livermore, D. M., Sefton, A. M. & Scott, G. M. Properties and potential of ertapenem. J. Antimicrob. Chemother. 52, 331–344 (2003).
Shah, P. M. & Isaacs, R. D. Ertapenem, the first of a new group of carbapenems. J. Antimicrob. Chemother. 52, 538–542 (2003).
Miller, T. W. Crystalline N-formimidoylthienamycin. US Patent 4260543 (1981).
McGowan, S. J., Bycroft, B. W. & Salmond, G. P. Bacterial production of carbapenems and clavams: evolution of β-lactam antibiotic pathways. Trends Microbiol. 6, 203–208 (1998).
Bycroft, B. W., Maslen, C., Box, S. J., Brown, A. & Tyler, J. W. The biosynthetic implications of acetate and glutamate incorporation into (3R,5R)-carbapenam-3-carboxylic acid and (5R)-carbapen-2-em-3-carboxylic acid by Serratia sp. J. Antibiot. (Tokyo) 41, 1231–1242 (1988).
Whitehead, N. A., Barnard, A. M., Slater, H., Simpson, N. J. & Salmond, G. P. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Rev. 25, 365–404 (2001).
McGowan, S. J. et al. Analysis of bacterial carbapenem antibiotic production genes reveals a novel β-lactam biosynthesis pathway. Mol. Microbiol. 22, 415–426 (1996). This is the first paper to describe the cloning and sequencing of a carbapenem biosynthetic gene cluster.
Holden, M. T. et al. Cryptic carbapenem antibiotic production genes are widespread in Erwinia carotovora: facile trans activation by the carR transcriptional regulator. Microbiology 144, 1495–1508 (1998).
Bell, K. S. et al. Genome sequence of the enterobacterial phytopathogen Erwinia carotovora subsp. atroseptica and characterization of virulence factors. Proc. Natl Acad. Sci. USA 101, 11105–11110 (2004).
McGowan, S. et al. Carbapenem antibiotic biosynthesis in Erwinia carotovora is regulated by physiological and genetic factors modulating the quorum sensing-dependent control pathway. Mol. Microbiol. 55, 526–545 (2005). A recent description of regulatory inputs into carbapenem production in Erwinia spp. These inputs were found to include QS as well as other environmental signals.
Welch, M. et al. N-acyl homoserine lactone binding to the CarR receptor determines quorum-sensing specificity in Erwinia. EMBO J. 19, 631–641 (2000).
Whitehead, N. A. et al. The regulation of virulence in phytopathogenic Erwinia species: quorum sensing, antibiotics and ecological considerations. Antonie Van Leeuwenhoek 81, 223–231 (2002).
Rivet, M. M. Investigation into the regulation of exoenzyme production in Erwinia carotovora subspecies carotovora. Thesis, Univ. Warwick, Coventry, UK (1998).
Cox, A. R. et al. A pheromone-independent CarR protein controls carbapenem antibiotic synthesis in the opportunistic human pathogen Serratia marcescens. Microbiology 144, 201–209 (1998).
Thomson, N. R., Crow, M. A., McGowan, S. J., Cox, A. & Salmond, G. P. Biosynthesis of carbapenem antibiotic and prodigiosin pigment in Serratia is under quorum sensing control. Mol. Microbiol. 36, 539–556 (2000).
Slater, H., Crow, M., Everson, L. & Salmond, G. P. Phosphate availability regulates biosynthesis of two antibiotics, prodigiosin and carbapenem, in Serratia via both quorum-sensing-dependent and-independent pathways. Mol. Microbiol. 47, 303–320 (2003). This report describes the regulatory control of antibiotic production in Serratia species. The study showed that the QS-mediated control of carbapenem biosynthesis operates in a different way from that in Erwinia species.
Coulthurst, S. J., Whitehead, N. A., Welch, M. & Salmond, G. P. Can boron get bacteria talking? Trends Biochem. Sci. 27, 217–219 (2002).
Xavier, K. B. & Bassler, B. L. LuxS quorum sensing: more than just a numbers game. Curr. Opin. Microbiol. 6, 191–197 (2003).
Coulthurst, S. J., Kurz, C. L. & Salmond, G. P. luxS mutants of Serratia defective in autoinducer-2-dependent 'quorum sensing' show strain-dependent impacts on virulence and production of carbapenem and prodigiosin. Microbiology 150, 1901–1910 (2004).
Thomson, N. R. et al. The Rap and Hor proteins of Erwinia, Serratia and Yersinia: a novel subgroup in a growing superfamily of proteins regulating diverse physiological processes in bacterial pathogens. Mol. Microbiol. 26, 531–544 (1997).
McGowan, S. et al. Carbapenem antibiotic production in Erwinia carotovora is regulated by CarR, a homologue of the LuxR transcriptional activator. Microbiology 141, 541–550 (1995).
McGowan, S. J. et al. Analysis of the carbapenem gene cluster of Erwinia carotovora: definition of the antibiotic biosynthetic genes and evidence for a novel β-lactam resistance mechanism. Mol. Microbiol. 26, 545–556 (1997).
Li, R., Stapon, A., Blanchfield, J. T. & Townsend, C. A. Three unusual reactions mediate carbapenem and carbapenam biosynthesis. J. Am. Chem. Soc. 122, 9296–9297 (2000). This is the first paper to describe the novel biochemistry involved in bacterial carbapenem biosynthesis.
Demain, A. L. & Elander, R. P. The β-lactam antibiotics: past, present, and future. Antonie Van Leeuwenhoek 75, 5–19 (1999).
Bycroft, B., Chhabra, S. R., Kellam, B. & Smith, P. Convenient syntheses of (3S,5S)-carbapenam-3-carboxylates and their biosynthetic relevance. Tetrahedron Lett. 44, 973–976 (2003).
Stapon, A., Li, R. & Townsend, C. A. Carbapenem biosynthesis: confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from L-proline. J. Am. Chem. Soc. 125, 8486–8493 (2003).
Sleeman, M. C. & Schofield, C. J. Carboxymethylproline synthase (CarB), an unusual carbon-carbon bond-forming enzyme of the crotonase superfamily involved in carbapenem biosynthesis. J. Biol. Chem. 279, 6730–6736 (2004).
Gerratana, B., Stapon, A. & Townsend, C. A. Inhibition and alternate substrate studies on the mechanism of carbapenam synthetase from Erwinia carotovora. Biochemistry 42, 7836–7847 (2003).
Miller, M. T., Gerratana, B., Stapon, A., Townsend, C. A. & Rosenzweig, A. C. Crystal structure of carbapenam synthetase (CarA). J. Biol. Chem. 278, 40996–41002 (2003). This paper reports the crystal structure of CarA, the β-LS that is involved in the carbapenem biosynthetic pathway in Erwinia species.
Miller, M. T., Bachmann, B. O., Townsend, C. A. & Rosenzweig, A. C. The catalytic cycle of β-lactam synthetase observed by X-ray crystallographic snapshots. Proc. Natl Acad. Sci. USA 99, 14752–14757 (2002).
Clifton, I. J. et al. Crystal structure of carbapenem synthase (CarC). J. Biol. Chem. 278, 20843–20850 (2003). This paper reports the crystal structure of the terminal biosynthetic enzyme CarC. This enzyme plays a key part in the generation of the active carbapenem antibiotic, through a novel catalytic pathway.
Townsend, C. A. New reactions in clavulanic acid biosynthesis. Curr. Opin. Chem. Biol. 6, 583–589 (2002).
Stapon, A., Li, R. & Townsend, C. A. Synthesis of (3S,5R)-carbapenam-3-carboxylic acid and its role in carbapenem biosynthesis and the stereoinversion problem. J. Am. Chem. Soc. 125, 15746–15747 (2003).
Topf, M. et al. The unusual bifunctional catalysis of epimerization and desaturation by carbapenem synthase. J. Am. Chem. Soc. 126, 9932–9933 (2004).
Sleeman, M. C. et al. Biosynthesis of carbapenem antibiotics: new carbapenam substrates for carbapenem synthase (CarC). Chembiochem. 5, 879–882 (2004).
Miller, M. T., Bachmann, B. O., Townsend, C. A. & Rosenzweig, A. C. Structure of β-lactam synthetase reveals how to synthesize antibiotics instead of asparagine. Nature Struct. Biol. 8, 684–689 (2001).
Maes, T. et al. The att locus of Rhodococcus fascians strain D188 is essential for full virulence on tobacco through the production of an autoregulatory compound. Mol. Microbiol. 42, 13–28 (2001).
Williamson, J. M. et al. Biosynthesis of the β-lactam antibiotic, thienamycin, by Streptomyces cattleya. J. Biol. Chem. 260, 4637–4647 (1985).
Abraham, E. P. & Chain, E. An enzyme from bacteria able to destroy penicillin. Nature 146, 837 (1940).
Abraham, E. P. in Antibiotics Containing the β-Lactam Structure I. (eds Demain, E. P. & Solomon, N. A.) 1–14 (Springer, Berlin, Heidelberg, 1983).
Aoki, H. et al. Nocardicin A, a new monocyclic β-lactam antibiotic. I. Discovery, isolation and characterization. J. Antibiot. 29, 492–500 (1976).
Reading, C. & Cole, M. Clavulanic acid: a β-lactamase-inhibiting β-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11, 852–857 (1977).
Holden, M. T. G. Molecular Genetic Analysis of Cryptic Antibiotic Genes in Erwinia carotovora subspecies carotovora. Thesis, Univ. Warwick, Coventry, UK (1996).
Martin, J. F. New aspects of genes and enzymes for β-lactam antibiotic biosynthesis. Appl. Microbiol. Biotechnol. 50, 1–15 (1998).
Gunsior, M. et al. The biosynthetic gene cluster for a monocyclic β-lactam antibiotic, nocardicin A. Chem. Biol. 11, 927–938 (2004).
Acknowledgements
The authors would like to thank the BBSRC, Sygen International Plc and NERC for financial support, and would also like to thank Martin Welch and members of the Salmond group for valuable discussions. We dedicate this paper to Barrie Bycroft, on his retirement, for stimulating our collaborative interest in carbapenems.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Related links
DATABASES
Entrez
Erwinia carotovora subsp. atroseptica
Photorhabdus luminescens strain TT01
SwissProt
FURTHER INFORMATION
Glossary
- FERMENTATION
-
An industrial process that is used to generate a microbially derived product in a fermenter, in which the growth conditions of the microorganism are tightly controlled and optimized to produce the maximum yield of the required product.
- SEMI-SYNTHESIS
-
This describes a process by which molecules of interest are produced by synthetic chemical modification of starting-point compounds that have been produced by microbial fermentation rather than by total chemical synthesis in vitro.
- CRYPTIC GENES
-
Cryptic genes are present in the genome of the microorganism of interest, but are not generally expressed. Crypticity can be due to mutations in regulatory genes. Alternatively, genes that are expressed might have non-functional protein products owing to mutations in the coding sequences.
- INTRINSIC RESISTANCE
-
Some bacteria are intrinsically resistant to specific antibiotics and have not acquired antibiotic resistance through gene mutation or horizontal gene transfer from another organism. Intrinsic resistance is particularly important for antibiotic-producing organisms, which must have a mechanism for avoiding the inhibitory effects of the antibiotic that they produce.
- CONSTITUTIVE EXPRESSION
-
This describes a constant level of gene expression rather than gene expression that is induced or repressed in response to a change in a physiological cue.
- DEREPRESSION
-
The removal of repression in response to a physiological signal, resulting in an up-regulation of expression of the corresponding target genes.
Rights and permissions
About this article
Cite this article
Coulthurst, S., Barnard, A. & Salmond, G. Regulation and biosynthesis of carbapenem antibiotics in bacteria. Nat Rev Microbiol 3, 295–306 (2005). https://doi.org/10.1038/nrmicro1128
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrmicro1128
This article is cited by
-
Structure of a B12-dependent radical SAM enzyme in carbapenem biosynthesis
Nature (2022)
-
A metallo-β-lactamase enzyme for internal detoxification of the antibiotic thienamycin
Scientific Reports (2021)
-
Antimicrobial secondary metabolites from agriculturally important bacteria as next-generation pesticides
Applied Microbiology and Biotechnology (2020)
-
Metabolic engineering of a carbapenem antibiotic synthesis pathway in Escherichia coli
Nature Chemical Biology (2018)
-
RNA-seq reveals the RNA binding proteins, Hfq and RsmA, play various roles in virulence, antibiotic production and genomic flux in Serratia sp. ATCC 39006
BMC Genomics (2013)